
Source: iQoncept / Shutterstock
TELA Bio (NASDAQ:TELA) has recently unveiled its financial report for the last quarter of 2023.
- Recording earnings per share of -53 cents, TELA Bio fell short of the projected EPS of -43 cents.
- The company disclosed a revenue figure of $17.00 million.
- This surpassed analyst forecasts by 3.71%, outshining the expected revenue of $16.39 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/tela-stock-earnings-tela-bio-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC